Search Results - "Wagenaar, L. J."

Heart failure admissions in adults with congenital heart disease; risk factors and prognosis by Zomer, A.C, Vaartjes, I, van der Velde, E.T, de Jong, H.M.Y, Konings, T.C, Wagenaar, L.J, Heesen, W.F, Eerens, F, Baur, L.H.B, Grobbee, D.E, Mulder, B.J.M

“…Abstract Background Heart failure (HF) is a serious complication and often the cause of death in adults with congenital heart disease (CHD). Therefore, our…”
Get full text

The first multicentre study on coronary anomalies in the Netherlands: MuSCAT by Koppel, C. J., Driesen, B. W., de Winter, R. J., van den Bosch, A. E., van Kimmenade, R., Wagenaar, L. J., Jukema, J. W., Hazekamp, M. G., van der Kley, F., Jongbloed, M. R. M., Kiès, P., Egorova, A. D., Verheijen, D. B. H., Damman, P., Schoof, P. H., Wilschut, J., Stoel, M., Speekenbrink, R. G. H., Voskuil, M., Vliegen, H. W.

“…Background Current guidelines on coronary anomalies are primarily based on expert consensus and a limited number of trials. A gold standard for diagnosis and…”
Get full text

Chronic fatigue syndrome in women assessed with combined cardiac magnetic resonance imaging by Olimulder, M. A. G. M., Galjee, M. A., Wagenaar, L. J., van Es, J., van der Palen, J., Visser, F. C., Vermeulen, R. C. W., von Birgelen, C.

“…Objective In chronic fatigue syndrome (CFS), only a few imaging and histopathological studies have previously assessed either cardiac dimensions/function or…”
Get full text

Pre-procedural ACE-activity does not predict symptomatic in-stent restenosis by Wagenaar, L.J., Rahel, B.M., van Boven, A.J., Voors, A.A., van der Wal, A.C., Plokker, H.W.M., van Gilst, W.H.

“…Several studies indicate that ACE-activity is related to atherosclerosis. We investigated the correlation between ACE-activity, in plasma as well as in the…”
Get full text

Non-intubated recovery from refractory cardiogenic shock on percutaneous VA-extracorporeal membrane oxygenation by van Houte, J., Donker, D.W., Wagenaar, L.J., Slootweg, A.P., Kirkels, J.H., van Dijk, D.

“…We report on the use of percutaneous femoral veno-arterial extracorporeal membrane oxygenation (VA-ECMO) in a fully awake, non-intubated and spontaneously…”
Get full text

‘Elevated’ hemidiaphragm due to a pericardial cyst by Borghouts, V.A.P., Stevenhagen, Y.J., Wagenaar, L.J., Bouman, D.E., Verhorst, P.M.J.

Get full text

Printed luminescent solar concentrators: Artistic renewable energy by Schiphorst, Jeroen ter, Cheng, Marx L.M.K.H.Y.K., van der Heijden, Maxime, Hageman, Renee L., Bugg, Emily L., Wagenaar, Teun J.L., Debije, Michael G.

“…The built environment and its direct surroundings show great potential for sustainable energy harvesting but often face the challenge of being integrated with…”
Get full text

Troglitazone. Is it all over? by Wagenaar, L J, Kuck, E M, Hoekstra, J B

“…In January 1997 a drug from a new pharmacological class, the thiazolidinediones, became available: troglitazone. Troglitazone indirectly enhances peripheral…”
Get more information

Obstructive intramyocardial haematoma after percutaneous coronary intervention by Slootweg, A. P., Louwerenburg, J. W., Mecozzi, G., Wagenaar, L. J., Verhorst, P. M. J.

Get full text

Infarct tissue characteristics of patients with versus without early revascularization for acute myocardial infarction: a contrast-enhancement cardiovascular magnetic resonance imaging study by Olimulder, M. A. G. M., Kraaier, K., Galjee, M. A., Scholten, M. F., van Es, J., Wagenaar, L. J., van der Palen, J., von Birgelen, C.

“…Histopathological studies have suggested that early revascularization for acute myocardial infarction (MI) limits the size, transmural extent, and homogeneity…”
Get full text

Contrast-enhancement cardiac magnetic resonance imaging beyond the scope of viability by Olimulder, M. A. G. M., Galjee, M. A., van Es, J., Wagenaar, L. J., von Birgelen, C.

“…The clinical applications of cardiovascular magnetic resonance imaging with contrast enhancement are expanding. Besides the direct visualisation of viable and…”
Get full text

Angiotensin II Type 2 Receptor Vasoactivity in Internal Mammary Arteries of Patients With Coronary Artery Disease by Wal, R. M. A van de, Harst, P van der, Wagenaar, L J, Wassmann, S, Morshuis, W J, Nickenig, G, Buikema, H, Plokker, H W. M, van Veldhuisen, D J, van Gilst, W H, Voors, A A

“…BACKGROUND:Several animal studies suggested that the angiotensin II type 2 (AT2) receptor subtype mediates vasodilation, yet the results in human arteries are…”
Get full text

Giant pseudoaneurysm after aortic root replacement by van de Wetering, M L J M, Wagenaar, L J, Bouma, B J, Koolbergen, D R

Get full text

Invasive testing leads to significantly altered (surgical) management strategy in coronary anomalies with interarterial course: 3 year interim analysis of MuSCAT by Verheijen, D B H, Van Der Kley, F, Egorova, A D, Jongbloed, M R M, Koolbergen, D R, Hazekamp, M G, Beijk, M A M, De Winter, R J, Damman, P, Wagenaar, L J, Post, M, Voskuil, M, Jukema, J W, Kies, P, Vliegen, H W

“…Abstract Introduction Diagnostic work-up of patients with an anomalous aortic origin of a coronary artery (AAOCA) includes an anatomical and functional…”
Get full text

Giant pseudoaneurysm after aortic root replacement by van de Wetering, M. L. J. M., Wagenaar, L. J., Bouma, B. J., Koolbergen, D. R.

Get full text

Effect of Intensive Versus Moderate Lipid Lowering on Endothelial Function and Vascular Responsiveness to Angiotensin II in Stable Coronary Artery Disease by van der Harst, Pim, Wagenaar, Lodewijk J., Buikema, Hendrik, Voors, Adriaan A., Plokker, H.W. Thijs, Morshuis, Wim J., Six, A. Jacob, Boonstra, Piet W., Nickenig, Georg, Wassmann, Sven, van Veldhuisen, Dirk J., van Gilst, Wiek H.

“…Recent evidence has demonstrated that intensive lipid-lowering therapy with a high-dose statin provides significant clinical benefit beyond moderate…”
Get full text

Angiotensin receptors in the cardiovascular system by Wagenaar, Lodewijk J, Voors, Adriaan A, Buikema, Hendrik, van Gilst, Wiek H

“…The angiotensin II receptors mediate the effects of the renin-angiotensin system, which has an important role in cardiovascular (patho)physiology. Four types…”
Get more information

Alternating bundle branch block by Wagenaar, L J, van Gelder, I C, van Veldhuisen, D J

Get full text

Differential localisation of the renin-angiotensin system in de-novo lesions and in-stent restenotic lesions in in-vivo human coronary arteries by WAGENAAR, Lodewijk J, VAN BOVEN, Ad J, VAN DER WAL, Allard C, AMOROSO, Giovanni, TIO, René A, VAN DER LOOS, Chris M, BECKER, Anton E, VAN GILST, Wiek H

“…Different components of the renin-angiotensin system (RAS) have been demonstrated in atherosclerotic plaques. However, the involvement of the RAS in in-stent…”
Get full text

Functional antagonism of different angiotensin II type I receptor blockers in human arteries by WAGENAAR, Lodewijk J, VOORS, Adriaan A, BUIKEMA, Hendrik, VAN BUITEN, Azuwerus, LÜBECK, Rob H, BOONSTRA, Piet W, VAN VELDHUISEN, Dirk J, VAN GILST, Wiek H

“…To evaluate and compare the functional type and the degree of antagonism of the selective angiotensin II type 1 receptor blockers (ARB) losartan, EXP 3174 (the…”
Get full text